Key result
Lipid metabolic abnormalities are linked to higher risk of preeclampsia development and progression.
Why the study?
Lipid metabolic abnormalities have emerged as potential risk factors for the development and progression of preeclampsia, but a comprehensive understanding of their roles is needed.
Design
Review
Authors
Loading...
May inform preeclampsia risk stratification; hypothesis-generating and requires prospective validation before clinical adoption.
This review highlights the role of lipid dysregulation in the pathogenesis of preeclampsia and suggests lipid-targeting as a potential therapeutic strategy.
Yu et al. (2022) conducted a review in Preeclampsia. Lipid metabolic abnormalities was evaluated. Lipid metabolic abnormalities and dysregulation of various lipid classes are potential risk factors for the development and progression of preeclampsia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: